retatrutide nonalcoholic steatohepatitis trial Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Fatty liver disease was alleviated

Plus, theres some evidence that recruits are allowed to meet lower standards

The second is standard medical practice

References Smith A, Jones B

Basically, we performed the recruiting of subjects who met the inclusion criteria within a study period

This study was an observational cohort investigation using electronic health record data from the United States Department of Veterans Affairs and included 606,434 patients with type 2 diabetes who newly started either a GLP-1 medication or, as a comparator, a sodium-glucose cotransporter-2 inhibitor (a type 2 diabetes medication that doesnt affect appetite and reward pathways) based on filled outpatient pharmacy records

The primary mechanism involves binding to GLP-1 receptors located throughout the body, particularly in the pancreas, brain, and gastrointestinal tract